Tomoyo Oguri

439 total citations
28 papers, 321 citations indexed

About

Tomoyo Oguri is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Tomoyo Oguri has authored 28 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Tomoyo Oguri's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Tomoyo Oguri is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Tomoyo Oguri collaborates with scholars based in Japan, United States and United Kingdom. Tomoyo Oguri's co-authors include Yukio Ando, Tomoya Shimokata, Yoshinori Hasegawa, Ayako Mitsuma, Takashi Shibata, Sachi Morita, Keisuke Uehara, Goro Nakayama, Kosuke Tanaka and Satoru Kitazono and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Science.

In The Last Decade

Tomoyo Oguri

26 papers receiving 321 citations

Peers

Countries citing papers authored by Tomoyo Oguri

Since Specialization

Citations

This map shows the geographic impact of Tomoyo Oguri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyo Oguri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyo Oguri more than expected).

Fields of papers citing papers by Tomoyo Oguri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyo Oguri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyo Oguri. The network helps show where Tomoyo Oguri may publish in the future.

Co-authorship network of co-authors of Tomoyo Oguri

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyo Oguri. A scholar is included among the top collaborators of Tomoyo Oguri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyo Oguri. Tomoyo Oguri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study 2023 ·Neuro-Oncology Advances ·Souichi Suenobu, Keita Terashima, Masaharu Akiyama, Tomoyo Oguri, (unknown), (unknown), (unknown), Karen So, Yoshihiro Nishida	7
2	A Case of Asymptomatic Pulmonary Nocardia cyriacigeorgica Infection With Mild Diabetes Mellitus 2022 ·Cureus ·(unknown), Morio Nakamura, Tomoyo Oguri, Daisuke Taniyama, Shinji Sasada	1
3	Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers 2022 ·Targeted Oncology ·Hiroyuki Takeda, (unknown), Kumiko Umemoto, (unknown), (unknown), Yoshiki Horie, Takuro Mizukami, Tomoyo Oguri, Takashi Ogura, Naoki Izawa, Hiroyuki Yamamoto, Yoshihisa Yamano, Yu Sunakawa	4
4	A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation 2021 ·Respiratory Medicine Case Reports ·Tomoyo Oguri, Shinji Sasada, Sachiko Seki, (unknown), (unknown), Kota Ishioka, Saeko Takahashi, (unknown), Shigemichi Hirose, Ryohei Katayama, Morio Nakamura	11
5	A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old woman 2020 ·BMC Pulmonary Medicine ·Shinji Sasada, (unknown), Tomoyo Oguri, (unknown), (unknown), (unknown), Kota Ishioka, Saeko Takahashi, Morio Nakamura, Masahiro Kaji	0
6	A case of congenital bronchial atresia patient with subclinical infection who underwent lung resection 2020 ·Respiratory Medicine Case Reports ·(unknown), Tomoyo Oguri, Shinji Sasada, (unknown), Kota Ishioka, Saeko Takahashi, Shoji Kuriyama, Masahiro Kaji, (unknown), Shigemichi Hirose, Morio Nakamura	3
7	Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017 2019 ·Lung Cancer ·(unknown), Ryo Ariyasu, Junji Koyama, (unknown), (unknown), (unknown), Tomoyo Oguri, Kakeru Hisakane, Ken Uchibori, Shingo Nishikawa, Satoru Kitazono, Noriko Yanagitani, Fumiyoshi Ohyanagi, Atsushi Horiike, Akihiko Gemma, Makoto Nishio	31
8	Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab 2019 ·Internal Medicine ·(unknown), Shingo Nishikawa, Hironori Ninomiya, Reiko Yoshida, (unknown), Tomoyo Oguri, Satoru Kitazono, Noriko Yanagitani, Atsushi Horiike, Fumiyoshi Ohyanagi, Yuichi Ishikawa, Makoto Nishio	10
9	Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib 2017 ·Anti-Cancer Drugs ·Ryo Ariyasu, (unknown), Junji Koyama, (unknown), (unknown), Yosuke Kawashima, (unknown), Tomoyo Oguri, Shingo Nishikawa, Satoru Kitazono, Noriko Yanagitani, Fumiyoshi Ohyanagi, Makoto Nishio	18
10	The reasons why re-biopsies were not performed after failure with EGFR-TKI. 2017 ·Journal of Clinical Oncology ·Tomoyo Oguri, Atsushi Horiike, Ryo Ariyasu, Junji Koyama, (unknown), (unknown), (unknown), Shingo Nishikawa, Satoru Kitazono, Noriko Yanagitani, Fumiyoshi Ohyanagi, Makoto Nishio	1
11	Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months. 2016 ·PubMed ·(unknown), Nobuyuki Hamajima, Yu Okada, Tomoyo Oguri, Toyoaki Murohara, Nobutaro Ban, Mitsuo Sato, Yoshinori Hasegawa	2
12	Extension of the Calvert formula to patients with severe renal insufficiency 2015 ·Cancer Chemotherapy and Pharmacology ·Tomoyo Oguri, Tomoya Shimokata, Isao Ito, Yoshinari Yasuda, Naoto Sassa, (unknown), Akinobu Hamada, Yoshinori Hasegawa, Yukio Ando	4
13	EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma 2015 ·Journal of Thoracic Oncology ·Kosuke Tanaka, Toyoaki Hida, Yuko Oya, Tomoyo Oguri, Tatsuya Yoshida, Junichi Shimizu, Yoshitsugu Horio, Akito Hata, Reiko Kaji, Shiro Fujita, Yoshitaka Sekido, Takeshi Kodaira, Masaki Kokubo, Nobuyuki Katakami, Yasushi Yatabe	54
14	Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer 2013 ·International Journal of Clinical Pharmacology and Therapeutics ·Tomoyo Oguri, Ayako Mitsuma, (unknown), Sachi Morita, Takashi Shibata, Tomoya Shimokata, (unknown), Goro Nakayama, Keisuke Uehara, Yoshinori Hasegawa, Yukio Ando	32
15	Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia 2013 ·International Journal of Clinical Oncology ·Takashi Shibata, Yosuke Minami, Ayako Mitsuma, Sachi Morita, (unknown), Tomoyo Oguri, Tomoya Shimokata, (unknown), Tomoki Naoe, Yukio Ando	21
16	Febrile complications after endobronchial ultrasound-guided transbronchial needle aspiration for intra-pulmonary mass lesions of lung cancer—a series of 3 cases 2012 ·Respiratory Investigation ·Tomoyo Oguri, (unknown), Kazuyoshi Imaizumi, Momen Elshazley, Izumi Hashimoto, Naozumi Hashimoto, Yoshinori Hasegawa	14
17	Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer 2012 ·Cancer Chemotherapy and Pharmacology ·Sachi Morita, Keisuke Uehara, Goro Nakayama, Takashi Shibata, Tomoyo Oguri, (unknown), Tomoya Shimokata, (unknown), Ayako Mitsuma, Yukio Ando	28
18	Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells 2011 ·Cancer Science ·Tetsunari Hase, Mitsuo Sato, Kenya Yoshida, Luc Girard, Yoshihiro Takeyama, (unknown), Momen Elshazley, Tomoyo Oguri, Yoshitaka Sekido, David S. Shames, Adi F. Gazdar, John D. Minna, Masashi Kondo, Yoshinori Hasegawa	26
19	Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis 2010 ·Cancer Chemotherapy and Pharmacology ·Tomoyo Oguri, Tomoya Shimokata, (unknown), Isao Ito, Yukio Ando, Yasutsuna Sasaki, Yoshinori Hasegawa	18
20	[Miliary tuberculosis and tuberculous peritonitis during infliximab treatment for rheumatoid arthritis]. 2010 ·PubMed ·Tomoyo Oguri, Satoru Ito, Mariko Morishita, Koji Sakamoto, Masashi Kondo, Yoshinori Hasegawa	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact